Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03152929 · ClinicalTrials.gov registry record · Phase 3
Paravertebral Block (PVC) Versus Pectoral Nerve Block (PEC)
A Phase 3 study, sponsored by Corewell Health West.
- Terminated
- Registry status
- Phase 3
- Development phase
- 89
- Enrollment target
NCT03152929: Clinical Trial Phase 3 study, sponsored by Corewell Health West.
NCT03152929 is a Phase 3 study that was terminated before completion, run by Corewell Health West. The registered enrollment target is 89 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03152929, a Phase 3 study, was terminated before completion, sponsored by Corewell Health West.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 89 participants
- Enrollment target
Study Summary
The purpose of this study is to compare two standard methods of pain control management used at Spectrum Health for patients undergoing breast surgery. The two methods being compared are the paravertebral block (PVB) and the pectoral nerve block (PEC). Postoperative pain control is essential following any major operative procedure. A variety of methods have been used to ensure adequate pain control, each with its own advantages and risks. Increasingly, attention has focused on regional methods of analgesia, which may allow for reduction in systemic narcotic use and their associated complications. Proposed benefits of regional analgesia and a resultant reduction in narcotic use include decreased risk of cancer progression, decreased length of stay, and decreased risk of ileus.
Primary Outcome
Participants for whom Narcotics were used for pain during surgery
Interventions
- DRUG Paravertebral Block
- DRUG Pectoral Nerve Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2017-03-09 |
| Est. Completion | 2019-05-21 |
| Phase | Phase 3 |
Why NCT03152929 stopped before completion
NCT03152929 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Paravertebral Block is the first listed.
NCT03152929 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03152929 about?
NCT03152929 is a clinical study titled "Paravertebral Block (PVC) Versus Pectoral Nerve Block (PEC)". The purpose of this study is to compare two standard methods of pain control management used at Spectrum Health for patients undergoing breast surgery. The two methods being compared are the paravertebral block (PVB) and the pectoral nerve block (PEC). Postoperative pain control is essential followi...
What is the current status of trial NCT03152929?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 89 participants. The study started on 2017-03-09. Estimated completion is 2019-05-21.
What interventions are being tested in trial NCT03152929?
The interventions under investigation include: Paravertebral Block (DRUG), Pectoral Nerve Block (DRUG).
Who is sponsoring clinical trial NCT03152929?
This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03152929's enrollment target sits among peer trials
89 1738th of 2000 higher than 262 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI